EXTENCILLINE 2.4 MUI, powder and solvent for injectable suspension IM bottle, 5 ml
Active ingredients: Benzathine benzylpenicillin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder and solvent for injectable suspensionbottle, 5 mlintramusculaire
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- EXTENCILLINE 2,4 MUI, poudre et solvant pour suspension injectable IM
- Pharmaceutical form
- poudre et solvant pour suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) en verre 2,4 MUI - 1 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- LABORATOIRES DELBERT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Mar 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64699367CIP73039095CIP133400930390955Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BENZATHINE BENZYLPÉNICILLINEpoudre | 2,4 MUI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.